Abstract
The genetic and epigenetic effects of nutritional folate deficiency were studied in two Chinese hamster ovary (CHO) cell lines. The CHO-AA8 cell line (hemizygous at the aprt locus) and CHO-UV5 (DNA repair-deficient mutant of AA8) were cultured in Ham's F-12 medium or in custom-prepared Ham's F-12 medium lacking folic acid, thymidine, and hypoxanthine. Cells cultured acutely in the folate deficient medium exhibited initial growth arrest, followed by massive cell death and DNA fragmentation into nucleosomal multimers characteristic of apoptosis. Although prolonged culture in the folate deficient medium was cytostatic and lethal to the majority cells, minor subpopulations in both cell lines failed to initiate cell death, exhibited phenotypic abnormalities, and adapted a selective growth advantage under marginal folate conditions. These “resistant” clones exhibited major alterations in deoxynucleotide pools associated with an increase in mutant frequency at the aprt locus as detected by resistance to cytotoxicity in 8-azaadenosine. The mutation frequency in the DNA repair-deficient CHO-UV5 cells was ∼100-fold greater than that in the parental AA8 clones, underscoring the importance of DNA repair under conditions of folate deficiency and nucleotide pool imbalance. The enhanced mutation frequency in the DNA repair-competent folate-deficient CHO-AA8 cells suggests that DNA repair activity is less effective under folate-deficient conditions. These results add to the accumulating clinical and experimental evidence relating chronic folate deficiency to genomic instability and carcinogenesis.
Footnotes
-
↵1 Supported by American Cancer Society Research Grant CN-73B (J. J.) and a National Center for Toxicological Research postgraduate fellowship (A. B.) administered by Oak Ridge Institute for Science and Education through an interagency agreement between the Department of Energy and the United States Food and Drug Administration.
-
↵2 To whom requests for reprints should be addressed.
- Received April 8, 1994.
- Accepted August 2, 1994.
- ©1994 American Association for Cancer Research.